Nanotechnology, including nanoscale drug delivery devices, is becoming steadily more common in the field of drug development and research. One example of this trend comes from Accelrys, which specializes in developing software for use in drug development work. Accelrys has enlisted some high-powered scientific help to broaden their level of expertise. MIT scientist Dr. Robert Langer has been brought in to provide additional insight into ways that software can be used to model new approaches in nanobiology. Article